89
Participants
Start Date
December 31, 2014
Primary Completion Date
July 31, 2017
Study Completion Date
September 30, 2017
dolutegravir
50 mg tablet by mouth once daily for 48 weeks
lamivudine
300 mg tablet by mouth once daily for 48 weeks
Continue current antiretroviral regimen
Continue current DHHS recommended or alternative three-drug antiretroviral regimen
Northwestern University, Chicago
University of California San Diego, San Diego
Emory University, Atlanta
Brigham and Women's Hospital, Boston
Cornell University, New York
University of Cincinnati, Cincinnati
The Ohio State University, Columbus
Collaborators (1)
ViiV Healthcare
INDUSTRY
Babafemi Taiwo
OTHER